Go BACK

OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 631 - 640 of 764 studies

Inflammatory and immune system Skin

A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Apremilast in Children from 5 to Less Than 18 Years of Age with Active Juvenile Psoriatic Arthritis (PEAPOD)

Multinational Anal Squamous Cell Carcinoma: Registry and Audit (mASCARA)

A Phase 3, multicenter, open label, randomized, non-comparative two-arm study of ivosidenib (IVO) monotherapy and azacitidine (AZA) monotherapy in adult patients with hypomethylating agent (HMA) naive myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation (PyramIDH study)

Neurological

A Phase 3, randomized, double-blind, study evaluating efficacy and safety of riliprubart versus intravenous immunoglobulin (IVIg) in participants with chronic inflammatory demyelinating polyneuropathy (VITALIZE)

Oxford Musculoskeletal Biobank RENEWAL

Natural History studies of participants with primary and secondary headache and facial pain disorders

Human brain mechanisms underlying motivation and apathy

Respiratory

Phase 2, Randomized, Double-blind, A Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Uncontrolled Asthma

Investigating the effects of beta transcranial stimulation to advance stroke rehabilitation (T-STAR)

Oxford Luteal Dysfunction and Placental Insufficiency Study (OxLuPIn)